Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma

Fig. 3

Clinical data and genetic aberrations in APC, CTNNB1, and other melanoma-associated genes in melanoma tissues that were sequenced with the Foundation One CDx assay from the combined UNC-CH/Vanderbilt/CPMRI patient cohort. Patient subsets with APC/CTNNB1 genetic aberrations (n = 32, panel A) and without APC/CTNNB1 mutations (n = 169, panel B) are shown. Abbreviations: Immunothtx, immunotherapies; n, no; y, yes; unkn, unknown

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us